Duquesne University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duquesne University sits in the top decile of US sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count).
Duquesne University: 21 sponsored US clinical trials, 1 recruiting.
Duquesne University sponsors 21 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 16 completed. 0 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Osteopenia, with 2 trials.
Top-decile sponsor footprint
Duquesne University ranks in the top decile of sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
16 of 17 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
21 total, page 1 of 1
Thirst for Knowledge
NCT07670767
Sweet Scents to Sweet Dreams
NCT06247696
Strength Training Effects on Musculoskeletal Health
NCT04810975
Melatonin and Osteogenic Loading on Osteopenia
NCT04233112
Empowering Parental Caregivers
NCT06173700
A Social Media Personalized Normative Feedback Intervention for Heavy Drinking College Students
NCT05608109
Home Program Practice for People With Language Disorders After Stroke
NCT04543084
Digital Support Intervention on Newly Licensed Nurses
NCT04100629
Meditation and Exercise to Treat Chronic Back Pain
NCT03324659
Effects of PSTon Mental Health Outcomes in Caregivers of Post-9/11 Combat Veterans With a Traumatic Brain Injury
NCT03211884
Music and Adherence Home Programs Post Stroke
NCT02906956
Efficacy of the START-Play Program for Infants With Neuromotor Disorders
NCT02593825
Project for Cognitive Advancement in Infants With Neuromotor Disorders
NCT02673658
The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program
NCT02431728
Exercise Dosing for Pain in Healthy Participants
NCT03642938
Melatonin-Micronutrients for Osteopenia Treatment Study
NCT01870115
Effect of Assessing Risk for Osteoporosis on Physician and Patient Behaviors
NCT01572766
Implementation of an Asthma Program to Improve Asthma Identification and Education in Children
NCT01692080
Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects
NCT00696839
Melatonin Osteoporosis Prevention Study
NCT01152580
Study on Impact of Lifestyle Change and Weight Loss Before Bariatric Surgery
NCT00623792
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
Therapeutic Areas
What is open in the Duquesne University pipeline
1 recruiting of 21 indexed (5% open); 16 completed (76%).
Phase mix: 0 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Osteopenia (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duquesne University: open-pipeline peers nationwide
Peers matched on 21 registered trials and 5% open enrollment, not the therapeutic-area sidebar.
Duquesne University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 21 trials (± recruiting share)
- AEterna Zentaris · 21 trials · 0% recruiting
- Amphastar Pharmaceuticals · 21 trials · 5% recruiting
- Apellis Pharmaceuticals · 21 trials · 10% recruiting
- Array Biopharma, now a wholly owned subsidiary of Pfizer · 21 trials · 0% recruiting
Sponsors near 5% open enrollment (± trial volume)
- Cook County Health · 5% recruiting · 21 trials
- David Grant U.S. Air Force Medical Center · 5% recruiting · 21 trials
- Legacy Health System · 5% recruiting · 21 trials
- Oregon Research Behavioral Intervention Strategies · 5% recruiting · 21 trials
Related
What to do with this Duquesne University page
21 registered trials is a research-attention snapshot, not an endorsement of Duquesne University or any single study.
- 1 of Duquesne University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Osteopenia is the condition Duquesne University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Osteopenia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duquesne University pipeline card: 21 registered trials from official public datasets.Report a data error.